Central lymphatic surgery

Lisanne Grünherz , Nicole Lindenblatt

Plastic and Aesthetic Research ›› 2023, Vol. 10 ›› Issue (1) : 20

PDF
Plastic and Aesthetic Research ›› 2023, Vol. 10 ›› Issue (1) :20 DOI: 10.20517/2347-9264.2023.24
Review

Central lymphatic surgery

Author information +
History +
PDF

Abstract

In recent years, microsurgical reconstruction of the lymphatic system has opened new frontiers in the treatment of central lymphatic lesions. Central lymphatic lesions can be congenital or acquired. While the latter can result from any surgery or trauma in the area of the thoracic duct, congenital lymphatic lesions can show a plethora of manifestations, ranging from singular thoracic duct abnormalities to complex multifocal malformations. Regardless of the anatomical location of the thoracic duct lesion, these conditions cause recurrent chylous effusions and downstream lymphatic congestion and are associated with increased mortality due to the permanent loss of protein and fluid. In case of disruption of the lymphatic flow, microsurgical reconstructive surgery is indicated to treat downstream congestion leading to bronchitis plastica, protein-loosing enteropathy, chylothorax, and chylascites. Thoracic duct-vein anastomoses can reconstruct the physiological lymphatic flow.

Keywords

Central conducting lymphatic anomaly / thoracic duct lesion / lympho-venous anastomosis / thoracic duct / central lymphatic lesion

Cite this article

Download citation ▾
Lisanne Grünherz, Nicole Lindenblatt. Central lymphatic surgery. Plastic and Aesthetic Research, 2023, 10(1): 20 DOI:10.20517/2347-9264.2023.24

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Gordon K,Keeley V.Update and audit of the St George's classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis.J Med Genet2020;57:653-9 PMCID:PMC7525776

[2]

Mäkinen T,Vikkula M.Lymphatic malformations: genetics, mechanisms and therapeutic strategies.Circ Res2021;129:136-54

[3]

Kupferman ME,Mandel SJ,Weber RS.Safety of modified radical neck dissection for differentiated thyroid carcinoma.Laryngoscope2004;114:403-6

[4]

Roh JL,Park CI.Chyle leakage in patients undergoing thyroidectomy plus central neck dissection for differentiated papillary thyroid carcinoma.Ann Surg Oncol2008;15:2576-80

[5]

Lee YS,Chang HS.Factors predisposing to chyle leakage following thyroid cancer surgery without lateral neck dissection.Head Neck2013;35:1149-52

[6]

Lee EW,Ko HK,Kim SH.Lymphangiography to treat postoperative lymphatic leakage: a technical review.Korean J Radiol2014;15:724-32 PMCID:PMC4248627

[7]

Ahn D,Jeong JY.Chyle fistula after neck dissection: an 8-year, single-center, prospective study of incidence, clinical features, and treatment.Ann Surg Oncol2015;22 Suppl 3:S1000-6

[8]

Park I,Choe JH,Kim JH.Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer.Head Neck2018;40:7-15

[9]

Trenor CC 3rd.Complex lymphatic anomalies.Semin Pediatr Surg2014;23:186-90

[10]

Lagarde SM,de Jong K.Incidence and management of chyle leakage after esophagectomy.Ann Thorac Surg2005;80:449-54

[11]

RochéRodríguez M.The lymphatic system in the fontan patient-pathophysiology, imaging, and interventions: what the anesthesiologist should know.J Cardiothorac Vasc Anesth2022;36:2669-78

[12]

Pieper CC,Schild HH.Contrast-enhanced Interstitial transpedal MR lymphangiography for thoracic chylous effusions.Radiology2020;295:458-66

[13]

Steven BR.Nutritional management in patients with chyle leakage: a systematic review.Eur J Clin Nutr2015;69:776-80

[14]

Liviskie CJ,McPherson CC.Propranolol for the treatment of lymphatic malformations in a neonate - a case report and review of literature.J Pediatr Pharmacol Ther2020;25:155-62 PMCID:PMC7025746

[15]

Hangul M,Ozcan A.Propranolol treatment for chylothorax due to diffuse lymphangiomatosis.Pediatr Blood Cancer2019;66:e27592

[16]

Ozeki M,Yasue S.The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.Orphanet J Rare Dis2019;14:141 PMCID:PMC6567608

[17]

Li D,Gutierrez-Uzquiza A.ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.Nat Med2019;25:1116-22

[18]

Swetman GL,Vasanawala SS,Lane AT.Sildenafil for severe lymphatic malformations.N Engl J Med2012;366:384-6

[19]

Morikawa K,Hasumi J.Retrograde transvenous lymphatic embolization for postoperative chylous ascites: a report of three cases and literature review.Radiol Case Rep2020;15:1623-8 PMCID:PMC7358384

[20]

Pieper CC,Sommer CM.Back to the future: lipiodol in lymphography-from diagnostics to theranostics.Invest Radiol2019;54:600-15

[21]

Schild HH,Wilhelm KE.Lymphatic interventions for treatment of chylothorax.Rofo2015;187:584-8

[22]

Schild HH.Where have all the punctures gone? an analysis of thoracic duct embolizations.J Vasc Interv Radiol2020;31:74-9

[23]

Kylat RI,Barber BJ,Ghishan FK.Resolution of protein-losing enteropathy after congenital heart disease repair by selective lymphatic embolization.Pediatr Gastroenterol Hepatol Nutr2019;22:594-600 PMCID:PMC6856498

[24]

Lindenblatt N,Broglie MA,Grünherz L.Lymphovenous anastomosis for the treatment of thoracic duct lesion: a case report and systematic review of literature.Ann Plast Surg2020;84:402-8

[25]

Hong JPJ,Suh HSP.Supermicrosurgery: principles and applications.J Surg Oncol2018;118:832-9

[26]

Weissler JM,Koltz PF.Lymphovenous anastomosis for the treatment of chylothorax in infants: a novel microsurgical approach to a devastating problem.Plast Reconstr Surg2018;141:1502-7

[27]

Miller TJ,Maeda K,Nguyen DH.Correction of complete thoracic duct obstruction with lymphovenous bypass: a case report.Microsurgery2019;39:255-8

[28]

Yuan Y,Zhao Y.Anastomosis between thoracic duct and azygos vein during esophagectomy: a novel technique with 3-year follow-up.World J Surg2016;40:2984-7

[29]

Rodi T,Fritsche E,Scaglioni MF.Direct repair of iatrogenic thoracic duct injury through lymphovenous anastomosis (LVA): a case report.J Surg Oncol2020;121:224-7

[30]

Feng J,Xiang F.Management of intractable pain in patients treated with hemorrhoidectomy for mixed hemorrhoids.Ann Palliat Med2021;10:479-83

[31]

Ciudad P,Bustos SS.The deep inferior epigastric lymphatic cable flap connected to gastroepiploic lymph node flap for treatment of refractory chylous ascites: report of two cases.Microsurgery2021;41:376-83

[32]

Ishiura R,Danno K,Inoue M.Successful treatment of large abdominal lymphatic malformations and chylous ascites with intra-abdominal lymphovenous anastomosis.J Vasc Surg Venous Lymphat Disord2021;9:499-503

[33]

Taghinia AH,Trenor CC 3rd.Lymphaticovenous bypass of the thoracic duct for the treatment of chylous leak in central conducting lymphatic anomalies.J Pediatr Surg2019;54:562-8

[34]

Othman S,Klifto K,Itkin M.Microsurgical thoracic duct lymphovenous bypass in the adult population.Plast Reconstr Surg Glob Open2021;9:e3875 PMCID:PMC8604011

[35]

Lindenblatt N,Vetter D.Lympho-venous anastomosis for the treatment of congenital and acquired lesions of the central lymphatic system: a multidisciplinary treatment approach.Eur J Plast Surg2022;45:841-9

[36]

Barbon C,Uyulmaz S,Lindenblatt N.Exploring the learning curve of a new robotic microsurgical system for microsurgery.JPRAS Open2022;34:126-33 PMCID:PMC9593278

[37]

Lindenblatt N,Wang A.Early Experience using a new robotic microsurgical system for lymphatic surgery.Plast Reconstr Surg Glob Open2022;10:e4013 PMCID:PMC8747501

[38]

Smith CL,O'Byrne ML,Gillespie MJ.Transcatheter thoracic duct decompression for multicompartment lymphatic failure after fontan palliation.Circ Cardiovasc Interv2022;15:e011733

PDF

68

Accesses

0

Citation

Detail

Sections
Recommended

/